Relaxation and Exercise In Lymphoma Patients (REIL)

  • Clinical Trials
  • London

ClinicalTrials.gov

clinical trial london,uk clinical research

ClinicalTrials.gov Identifier:
NCT02272751

Purpose

This study will aim to compare the effects of an Exercise programme and a Relaxation Intervention in lymphoma patients in remission post-chemotherapy on quality of life, cardiovascular fitness, exercise tolerance, muscle strength, psychological status, social well-being and biological markers.

Subjects will be recruited from a specialist lymphoma clinic in South West London and randomly allocated to an exercise or a relaxation home programme. The study aims to determine the more effective intervention of the two in relation to the outcome measures.

The investigators anticipate that the interventions will result in less adverse events and improved quality of life and physical fitness, and subjects will require less medication, less counseling and cancer nurse specialist care, leading to leading to a reduction in hospital and surgery attendances.

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care

Eligibility

Ages Eligible for Study:
18 Years and older
Genders Eligible for Study:
Both
Accepts Healthy Volunteers:
No

Criteria
Inclusion Criteria:

Patients with histologically confirmed lymphoma in remission post-chemotherapy
Age 18 years or older
Ability to give informed consent
Good Performance status (ECOG 0-2)
Clinically able to carry out exercise training programme on a regular basis

Exclusion Criteria:

Patients with progressive disease
Poor performance status (ECOG status 3 or more)
Abnormal resting ECG unexplained by further cardiological investigations
Pregnancy
Difficulty breathing at rest
Persistent cough, fever or illness
Cognitive impairment sufficient to limit ability to perform quality of life questionnaires or understand instructions

Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02272751

Contacts
Contact: Ruth Pettengell, MBChB PhD 02087255454 rpetteng@sgul.ac.uk
Contact: Suchita Hathiramani, MSc, BSc 07760246770 s.hathiramani@sgul.kingston.a.cuk

Locations
United Kingdom
Haematology and Oncology Outpatient Clinic, St. George’s Hospital, Blackshaw Road Recruiting
Tooting, London, United Kingdom, SW17 0QT
Contact: Ruth Pettengell, MBChB PhD 02087255454 rpetteng@sgul.ac.uk
Contact: Suchita Hathiramamni, MSc BSc 07760246770
Principal Investigator: Ruth Pettengell, MBChB PhD
Sub-Investigator: Suchita Hathiramani, MSc BSc

To apply for this job please visit the following URL: https://www.clinicaltrials.gov/ct2/show/study/NCT02272751 →